Objective: The purpose of this study was to determine the ex vivo human placental transfer of rifampin and rifabutin.
proportionately less accumulation of rifabutin in the fetal circulation when compared to rifampin. Infect. Dis 1,z Another member of this class of antibiotics is rifabutin, a semisynthetic derivative of rifamycin S, which is currently used in immunosuppressed individuals to provide prophylaxis against and treatment for J/. avium complex (MAC) infections. 3, 4 Rifabutin has also been shown to 
RESULTS
Reproducibility studies for the HPLC determination of both rifampin and rifabutin concentrations in the perfusates and tissue samples were >9S% with a minimum sensitivity of <0.1 pg/ml (data not shown).
Determinations of the clearance indices of rifampin and rifabutin revealed that rifabutin had a significantly higher clearance index than that of rifampin at both the 1.0 and 10.0 pg/ml concentrations (Table 1 ). There was no significant difference between rifampin's or rifabutin's accumulation in the fetal compartment ( Table 2 ).
The determination of rifampin's and rifabutin's placental tissue concentrations noted a higher concentration of rifabutin in the tissue when compared to rifampin, but this was not statistically significant (Table 3) . Rifabutin perfused placental tissue was noted to have 100% of the concentration of the maternal compartment. As expected, there was an appropriate decrease in the concentration of each drug in the maternal perfusate at the end of the closed/closed (recirculating) perfusion study (Table 4) . 
